Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
29.18
+0.38 (1.30%)
Jul 28, 2026, 2:58 PM EDT - Market open
Genmab Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,521 | 1,715 | 1,380 | 2,201 | 1,424 | 1,370 |
Short-Term Investments | - | - | 1,574 | 1,965 | 1,789 | 1,588 |
Cash & Short-Term Investments | 1,521 | 1,715 | 2,954 | 4,166 | 3,213 | 2,957 |
Cash Growth | -52.85% | -41.94% | -29.09% | 29.65% | 8.65% | 12.04% |
Accounts Receivable | - | - | 923 | 732.47 | 822.14 | 514.9 |
Other Receivables | 1,031 | 1,152 | 14 | - | 26.2 | 4.74 |
Total Trade Receivables | 1,031 | 1,152 | 937 | 732.47 | 848.34 | 519.64 |
Inventory | 21 | 18 | 9 | 8.44 | - | - |
Total Current Assets | 2,573 | 2,885 | 3,900 | 4,907 | 4,061 | 3,477 |
Net Property, Plant & Equipment | 265 | 280 | 265 | 242.97 | 190.28 | 149.1 |
Other Intangible Assets | 8,948 | 9,123 | 1,728 | 14.95 | 21.01 | 38.84 |
Goodwill | 355 | 355 | 355 | - | - | - |
Long-Term Investments | 40 | 37 | 32 | 19.84 | 19.14 | 56.74 |
Other Long-Term Assets | 195 | 193 | 134 | 40.57 | 43.18 | 44.5 |
Total Assets | 12,376 | 12,873 | 6,414 | 5,225 | 4,335 | 3,766 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accrued Expenses | 861 | 1,069 | 489 | 341.58 | 246.99 | 226.33 |
Current Portion of Long-Term Debt | 275 | 273 | - | - | - | - |
Current Portion of Leases | 18 | 18 | 13 | 13.33 | 10.65 | 9.48 |
Unearned Revenue | 24 | 24 | 3 | 4.89 | 4.75 | 3.98 |
Other Current Liabilities | - | 43 | 239 | 8 | - | - |
Total Current Liabilities | 1,178 | 1,427 | 744 | 367.79 | 262.39 | 239.79 |
Long-Term Debt | 4,933 | 5,001 | - | - | - | - |
Long-Term Leases | 125 | 134 | 131 | 100.68 | 75.28 | 55.51 |
Other Long-Term Liabilities | 458 | 464 | 402 | 76.25 | 70.67 | 76.46 |
Total Long-Term Liabilities | 5,516 | 5,599 | 533 | 176.94 | 145.95 | 131.98 |
Total Liabilities | 6,694 | 7,026 | 1,277 | 544.72 | 408.34 | 371.76 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 10 | 10 | 10 | 9.77 | 9.5 | 10.09 |
Additional Paid-in Capital | 1,922 | 1,920 | 1,961 | 1,845 | 1,772 | 1,840 |
Accumulated Other Comprehensive Income | -340 | -181 | -226 | 8.88 | 14.11 | 12.39 |
Retained Earnings | 4,090 | 4,098 | 3,392 | 2,817 | 2,131 | 1,532 |
Shareholders' Equity | 5,682 | 5,847 | 5,137 | 4,680 | 3,927 | 3,394 |
Total Liabilities & Equity | 12,376 | 12,873 | 6,414 | 5,225 | 4,335 | 3,766 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 5,351 | 5,426 | 144 | 114.01 | 85.93 | 64.99 |
Net Cash (Debt) | -3,830 | -3,711 | 2,810 | 4,052 | 3,127 | 2,892 |
Net Cash Growth | - | - | -30.65% | 29.56% | 8.12% | 11.80% |
Net Cash Per Share | -6.85 | -5.92 | 4.35 | 6.15 | 4.74 | 4.38 |
Book Value | 5,682 | 5,847 | 5,137 | 4,680 | 3,927 | 3,394 |
Book Value Per Share | 10.16 | 9.33 | 7.95 | 7.10 | 5.95 | 5.14 |
Tangible Book Value | -3,621 | -3,631 | 3,054 | 4,665 | 3,906 | 3,356 |
Tangible Book Value Per Share | -6.48 | -5.79 | 4.72 | 7.08 | 5.92 | 5.08 |